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SCIENTIFIC OPINION 
Scientific Opinion on application EFSA-GMO-NL-2011-97 for the placing 
on the market of insect-resistant and herbicide-tolerant genetically 
modified cotton T304-40 for food and feed uses, import and processing 
under Regulation (EC) No 1829/2003 from Bayer CropScience AG
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2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
 
This scientific output, published on 29 July 2013, replaces the earlier version published on 20 June 
2013
4
. 
ABSTRACT 
Cotton T304-40 contains a single insert consisting of the cry1Ab and the bar expression cassettes, providing 
insect resistance and herbicide tolerance, respectively. Bioinformatic analyses and genetic stability studies did 
not raise safety issues. Levels of the Cry1Ab and PAT proteins in cotton T304-40 have been sufficiently 
analysed. No biologically relevant differences were identified in the compositional analysis when the seed of 
T304-40 was compared with its conventional counterpart and non-GM cotton varieties. The safety assessment 
identified no concerns regarding the potential toxicity and allergenicity of the newly introduced Cry1Ab and 
PAT proteins. Based on the information available, there is no evidence that the genetic modification might 
significantly change the overall allergenicity of cotton T304-40. Nutritional equivalence of cotton T304-40 to its 
conventional counterparts was indicated by compositional data. The EFSA GMO Panel concludes that cotton 
T304-40 is as safe and nutritious as its conventional counterpart and that it is unlikely that the overall 
allergenicity of the whole plant is changed. There are no indications of an increased likelihood of establishment 
and spread of feral cotton plants. Considering its intended uses as food and feed, interactions with the biotic and 
abiotic environment were not considered to be an issue. Risks associated with an unlikely but theoretically 
possible horizontal gene transfer from cotton T304-40 to bacteria have not been identified. The monitoring plan 
and reporting intervals are in line with the intended uses of cotton T304-40. The EFSA GMO Panel considers 
that the information available for cotton T304-40 addresses the scientific comments raised by the Member States 
and states that cotton T304-40, as described in the application, is as safe as its conventional counterpart with 
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respect to potential effects on human and animal health and the environment in the context of its intended uses as 
proposed by the applicant. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following the submission of an application (Reference EFSA-GMO-NL-2011-97) under Regulation 
(EC) No 1829/2003
5
 from Bayer CropScience AG, the Panel on Genetically Modified Organisms of 
the European Food Safety Authority (EFSA GMO Panel) was asked to deliver a scientific opinion on 
the safety of the insect-resistant and herbicide-tolerant genetically modified (GM) cotton T304-40 
(Unique Identifier BCS-GHØØ4-7) for import and processing for food and feed uses. Cotton T304-40 
was developed to provide resistance to certain lepidopteran pests and tolerance to glufosinate 
ammonium-based herbicides. 
In delivering its scientific opinion, the EFSA GMO Panel considered the application EFSA-GMO-NL-
2011-97, additional information provided by the applicant (Bayer CropScience AG) and the scientific 
comments submitted by the Member States. The scope of application EFSA-GMO-NL-2011-97 is for 
food and feed uses, import and processing of cotton T304-40 and all derived products, but excludes 
cultivation in the European Union (EU). 
The EFSA GMO Panel evaluated cotton T304-40 with reference to the intended uses and appropriate 
principles described in the guidance documents of the Scientific Panel on Genetically Modified 
Organisms for the risk assessment of food and feed derived from genetically modified plants (EFSA, 
2006a, 2011a). The scientific risk assessment evaluation included molecular characterisation of the 
inserted DNA and expression of target proteins. A comparative analysis of agronomic traits and 
composition was undertaken, and the safety of the new proteins, as individual proteins and in 
combination, the changed levels of natural constituents and the whole food/feed were evaluated with 
respect to potential toxicity, allergenicity and nutritional quality. Evaluations of environmental 
impacts and the post-market environmental monitoring plan were undertaken. 
Cotton T304-40 has been genetically modified to express the proteins Cry1Ab and phosphinothricin 
acetyltransferase (PAT). Cry1Ab is an insecticidal protein deriving from Bacillus thuringiensis strain 
berliner 1715. PAT is encoded by the bar gene deriving from Streptomyces hygroscopicus. PAT 
confers tolerance to glufosinate ammonium-based herbicides. 
The molecular characterisation data establish that the GM cotton T304-40 contains a single insert 
consisting of copies of the cry1Ab and the bar expression cassettes. No other parts of the plasmid used 
for transformation are present in cotton T304-40. Bioinformatic analyses and genetic stability studies 
did not raise safety issues. The levels of the Cry1Ab and PAT proteins in cotton T304-40 have been 
sufficiently analysed. 
Based on the results of compositional analysis of samples from a representative range of environments 
and seasons, the EFSA GMO Panel concludes that no biologically relevant differences were identified 
in the compositional characteristics of seeds produced by cotton T304-40 compared with its 
conventional counterpart, Coker 315, and that its composition falls within the range of estimated 
natural variation, except for the expression of the Cry1Ab and PAT. In addition, results from field 
trials did not show indications of unexpected changes in agronomic performance and phenotypic 
characteristics. 
The EFSA GMO Panel has previously evaluated the safety of the Cry1Ab and PAT proteins in the 
context of several applications for the placing on the EU market of GM crops expressing these 
proteins, and no concerns were identified. The results of the updated bioinformatic analysis provided 
in the context of this application do not change these conclusions. In the context of this application the 
applicant has provided an acute toxicity of Cry1Ab in mice and resistance to degradation by 
proteolytic enzymes studies of Cry1Ab and PAT proteins associated with the event T304-40. The 
                                                     
5 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. OJ L 268, 1–23. 
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Cry1Ab protein induced no adverse effects in acute oral toxicity study in rodents. Both proteins were 
rapidly degraded solutions containing pepsin and inactivated during heat treatments. 
The safety assessment identified no concerns regarding the potential toxicity and allergenicity of the 
newly introduced Cry1Ab and PAT proteins. Based on the information available, there is no evidence 
that the genetic modification might significantly change the overall allergenicity of cotton T304-40. 
Nutritional equivalence of cotton T304-40 to its conventional counterparts was indicated by 
compositional data. The EFSA GMO Panel concludes that cotton T304-40 is as safe and nutritious as 
its conventional counterpart and that it is unlikely that the overall allergenicity of the whole plant is 
changed. 
The application EFSA-GMO-NL-2011-97 concerns food and feed uses, import and processing. 
Therefore, there is no requirement for scientific information on possible environmental effects 
associated with the cultivation of cotton T304-40 in Europe. There are no indications of an increased 
likelihood of establishment and spread of feral cotton plants in case of accidental release into the 
environment of viable cotton T304-40 seeds during transport and/or processing. Considering its 
intended uses as food and feed, interactions with the biotic and abiotic environment were not 
considered to be an issue. Risks associated with an unlikely but theoretically possible horizontal gene 
transfer from cotton T304-40 to bacteria have not been identified. The scope of the post-market 
environmental monitoring plan provided by the applicant is in line with the intended uses of cotton 
T304-40. Furthermore, the EFSA GMO Panel agrees with the reporting intervals proposed by the 
applicant in the post-market environmental monitoring plan. 
In conclusion, the EFSA GMO Panel considers that the information available for cotton T304-40 
addresses the scientific issues indicated by the guidance document of the EFSA GMO Panel and the 
scientific comments raised by the Member States, and that cotton T304-40 is as safe as its comparator 
with respect to potential effects on human and animal health or the environment in the context of its 
intended uses. 
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BACKGROUND 
On 7 April 2011, EFSA received from the Competent Authority of the Netherlands an application 
(Reference EFSA-GMO-NL-2011-97), for authorisation of insect-resistant and herbicide-tolerant GM 
cotton T304-40 (Unique Identifier BCS-GHØØ4-7), submitted by Bayer CropScience AG within the 
framework of Regulation (EC) No 1829/2003 on genetically modified food and feed for food and feed 
uses, import and processing. 
After receiving the application EFSA-GMO-NL-2011-97 and in accordance with Articles 5(2)(b) and 
17(2)b of Regulation (EC) No 1829/2003, EFSA informed the Member States as well as the European 
Commission and made the summary of the dossier publicly available on the EFSA website. EFSA 
initiated a formal review of the application to check compliance with the requirements laid down in 
Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 29 August 2011 and 3 October 2011, 
the applicant provided EFSA with additional information requested under completeness check 
(requested on 26 May 2011 and 12 September 2011, respectively). On 24 October 2011, EFSA 
declared the application as valid in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 
1829/2003. 
EFSA made the valid application available to Member States and the European Commission and 
consulted nominated risk assessment bodies of the Member States, including the national Competent 
Authorities within the meaning of Regulation (EC) No 1829/2003 and Directive 2001/18/EC
6
 
following the requirements of Articles 6(4) and 18(4) of Regulation (EC) No 1829/2003, to request 
their scientific opinion. The Member State bodies had three months after the date of receipt of the 
valid application (until 24 January 2012) within which to make their opinion known. 
The EFSA GMO Panel carried out a scientific assessment of genetically modified (GM) cotton T304-
40 in accordance with Articles 6(6) and 18(6) of Regulation (EC) No 1829/2003, taking into account 
the appropriate principles described in the guidance documents of the Scientific Panel on Genetically 
Modified Organisms for the risk assessment of food and feed derived from genetically modified plants 
(EFSA, 2006a, 2011a). In addition, the scientific comments of Member States, the additional 
information provided by the applicant and relevant scientific publications were taken into 
consideration. 
On 5 December 2011 and on 23 April 2012 the GMO Panel asked for additional data on cotton T304-
40 (application EFSA-GMO-NL-2011-97). The applicant provided the requested information on 22 
March 2012 and on 6 June 2012, respectively. In addition, on 2 May 2013, the applicant provided 
additional information spontaneously. After receipt and assessment of the full data package, the GMO 
Panel finalised its risk assessment of cotton T304-40. 
In giving its opinion on GM cotton T304-40 to the European Commission, the Member States and the 
applicant, and in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA 
has endeavoured to respect a time limit of six months from the receipt of the valid application. As 
additional information was requested by the EFSA GMO Panel, the time limit of 6 months was 
extended accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 
1829/2003. 
According to Regulation (EC) No 1829/2003, the EFSA opinion shall include a report describing the 
assessment of the food and feed and stating the reasons for its opinion and the information on which 
its opinion is based. This document is to be seen as the report requested under Articles 6(6) and 18(6) 
of that Regulation and thus will be part of the overall opinion in accordance with Articles 6(5) and 
18(5). 
                                                     
6 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L106, 1–39. 
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TERMS OF REFERENCE 
The GMO Panel was requested to carry out a scientific assessment of the GM cotton T304-40 (Unique 
Identifier BCS-GHØØ4-7) for food and feed uses, import and processing in accordance with Articles 
6(6) and 18(6) of Regulation (EC) No 1829/2003. Where applicable, any conditions or restrictions 
which should be imposed on the placing on the market and/or specific conditions or restrictions for use 
and handling, including post-market monitoring requirements based on the outcome of the risk 
assessment and, in the case of GMOs or food/feed containing or consisting of GMOs, conditions for 
the protection of particular ecosystems/environments and/or geographical areas should be indicated in 
accordance with Articles 6(5)(e) and 18(5)e of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give an opinion on information required under Annex II 
to the Cartagena Protocol, nor on the proposals for labelling and methods of detection (including 
sampling and the identification of the specific transformation event in the food/feed and/or food/feed 
produced from it), which are matters related to GMO risk management. 
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ASSESSMENT 
1. Introduction 
Genetically modified (GM) cotton T304-40 (Unique Identifier BCS-GHØØ4-7) was assessed with 
reference to its intended uses, taking account of the appropriate principles described in the guidance 
documents of the Scientific Panel on Genetically Modified Organisms for the risk assessment of food 
and feed derived from genetically modified plants (EFSA, 2006a, 2011a). 
The genetic modification in cotton T304-40 results in the expression of the PAT and Cry1Ab proteins, 
which confer tolerance to glufosinate ammonium-based herbicides and resistance to certain 
lepidopteran insects, respectively. The genetic modification in cotton T304-40 is intended to improve 
agronomic performance only and it is not intended to influence the nutritional properties, processing 
characteristics and overall use of cotton as a crop. 
The scope of application EFSA-GMO-NL-2011-97 is for food and feed use, import and processing of 
cotton T304-40 within the EU. Thus, cotton T304-40 would be used for the production of cotton 
products as any commercial cotton variety. Likely uses of cotton T304-40 include the production of 
refined oil from seeds, production of cellulose from linters as food or food ingredients and use of 
cotton seed meal and hulls in animal feed. 
2. Issues raised by Member States 
The scientific comments raised by Member States are addressed in Annex G of the EFSA overall 
opinion and have been considered throughout this EFSA GMO Panel scientific opinion. 
3. Molecular characterisation 
3.1. Evaluation of relevant scientific data 
3.1.1. Transformation process and vector constructs 
Cotton T304-40 was developed by Agrobacterium tumefaciens-mediated transformation. Cotyledon 
explants of Gossypium hirsutum variety Coker 315 were co-cultured with a disarmed A. tumefaciens 
strain containing the vector pTDL008.
7
 
The pTDL008 vector includes one T-DNA, which contains two expression cassettes between the right 
and left borders.
8
 
The cry1Ab cassette confers the insect resistance. It consists of the following genetic elements: a 
duplicated promoter derived from Subterranean clover stunt virus genome segment 7 (Ps7s7); leader 
sequence of the tapetum-specific E1 gene from Oryza sativa (5 e1); a synthetic sequence derived from 
the cry1Ab gene of Bacillus thuringiensis strain berliner 1715, which encodes the N-terminal part of 
the proprotein sufficient to produce a functional toxin; 3′ untranslated region of the NADP-malic 
enzyme encoding gene from Flaveria bidentis (3′ me1). 
The bar cassette confers tolerance to glufosinate ammonium-based herbicides. It contains the 35S 
promoter from Cauliflower mosaic virus (P35S3); the coding sequence of the phosphinothricin 
acetyltransferase gene from Streptomyces hygroscopicus (bar); and the 3′ untranslated region of the 
nopaline synthase gene from A. tumefaciens (3′ nos). 
The vector backbone contained elements necessary for the maintenance and selection of the plasmid in 
bacteria: ori ColE1, the origin of replication from plasmid pBR322, required for the maintenance of 
                                                     
7 Technical Dossier/Section C1 
8 Technical Dossier/Section C2 
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pTDL008 in Escherichia coli; ori pVS1, the origin of replication from the Pseudomonas plasmid 
pVS1, for the maintenance of the plasmid vector in Agrobacterium; a fragment of the bacterial nptI 
gene; the bacterial aadA gene, conferring resistance to streptomycin; and residual sequences of 
pTiAch5 flanking the left and right border repeats. 
3.1.2. Transgene constructs in the genetically modified plant 
Molecular characterisation of cotton event T304-40 was performed by Southern analysis and 
sequencing, to determine copy number, size and organisation of the inserted sequences and to confirm 
the absence of plasmid backbone sequence.
9
 The approach used was acceptable in terms of both 
coverage and sensitivity. 
Southern blot hybridisation data demonstrated that the inserted transgenic sequence in cotton event 
T304-40 consists of one nearly complete copy of the T-DNA, flanked by an inverted incomplete copy 
of the crylAb gene cassette and one additional 3′ me1 terminator and a partial copy of the bar 
expression cassette, containing a truncated 3′ nos terminator. The organisation of the insert was 
confirmed by the hybridisation signals generated with a set of 10 different restriction enzymes in 
combination with seven distinct probes. The absence of vector backbone was demonstrated by 
Southern analysis, using seven overlapping probes.
10
 
Results of the sequence analysis of the insert in cotton T304-40 and its 5′ and 3′ flanking regions were 
in line with those indicated by the Southern analyses. A comparison of the pre-insertion locus in wild-
type cotton with T304-40 indicated that the pre-insertion locus was preserved except for the deletion 
of 32 bp. Alignment of the insert sequence with the corresponding regions of pTDL008 indicated that 
they are identical except for a single nucleotide change in the copy of the non-coding 3′ me1 
terminator region located close to the 5′ junction.11 Bioinformatic analyses of the genomic sequences 
flanking the insert and the pre-insertion site were carried out to assess any potential interruption of 
known cotton genes.
12
 BLASTN searches were performed against plant EST (Expressed Sequence 
Tag) database and non-redundant nucleotide database and BLASTX searches against non-redundant 
amino acid database, and the results did not indicate the interruption of any known gene in cotton 
T304-40. The results also confirmed that the insert is located in the nuclear genome. 
In order to assess whether the open reading frames (ORFs) present within the insert and spanning the 
junction sites raise any safety issue, their putative translation products were compared with appropriate 
databases for similarities to known allergens and toxins by using suitable algorithms.
13
 None of the 
ORF translation products identified spanning the junction sites in cotton T304-40 showed biologically 
significant sequence similarities with known toxins or allergens. Epitope homology searches showed 
identity between a contiguous block of 8 amino acids of an ORF present within the insert (ORF.100) 
and two known allergens belonging to the glycinin G5 subgroup. Apart from this epitope match, 
ORF.100 does not show above-threshold similarity to any allergens as defined by Codex Alimentarius 
(2009) and the EFSA scientific opinion on assessment of allergenicity of GM plants (EFSA, 2010a). 
Although ORF.100 does not have a start codon, the applicant performed northern analysis on RNA 
extracted from cotton T304-40.
14
 No mRNA containing ORF.100 as an exon could be detected, which 
provides additional evidence that the expression of ORF.100 is unlikely. 
3.1.3. Information on the expression of the insert 
Cotton T304-40 expresses two new proteins, Cry1Ab and PAT. Protein levels were analysed in 
greenhouse-grown plants by enzyme-linked immunosorbent assay (ELISA) in roots, stems, leaves, 
                                                     
9 Technical Dossier/Section D2 
10 Technical Dossier/Section D2 (a) 
11 Technical Dossier/Section D2 (c) 
12 Technical Dossier/Section D2 (b) 
13 Technical Dossier/Section D2 (b) 
14 Additional information, June 2012 
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squares, apices, bolls, pollen, nectar, flowers and seeds. Considering the scope of the application, the 
Cry1Ab and PAT protein levels in seeds are considered most relevant. The levels of the newly 
expressed proteins were determined in seeds harvested from field trials performed in the USA (2007) 
and in Spain (2008) at locations representing typical cotton-growing regions.
15
 Each site contained 
both glufosinate ammonium-treated and untreated plots. In 2007 and 2008, data were collected from 
eight and six sites, respectively. The mean Cry1Ab level for seed across all USA sites was 0.562 μg/g 
fresh weight (fw) (range 0.527–1.57 μg/g fw); the corresponding value for the European trials was 
2.63 μg/g fw (range 1.77–3.63 μg/g fw). The mean PAT level for seeds across all USA sites was 
97.7 μg/g fw (range 67.5–138 μg/g fw); the corresponding value for the European trials was 146 μg/g 
fw (range 97.8–222 μg/g fw). The results showed that the means and ranges of Cry1Ab and PAT 
proteins in cotton T304-40 grown in 2007 in the USA were generally lower than those observed in 
samples collected from cotton T304-40 grown in 2008 in Spain. Variations in protein levels such as 
those observed are not unexpected in different field trials, and do not pose a safety concern per se. 
Comparison of the herbicide-treated and untreated plots indicated that glufosinate ammonium 
treatment had no significant effect on the levels of the newly expressed proteins in seeds. 
The possible presence of potential fusion proteins in cotton T304-40 was analysed because of the 
truncated terminators in the insert. Although northern analysis showed the presence of read-through 
transcripts of the cry1Ab gene, western analysis did not indicate fusion proteins. Prior bioinformatic 
analysis of the DNA sequences corresponding to the read-through transcripts did not show similarity 
to known toxins and allergens. Northern analysis did not reveal any read-through transcripts from the 
bar gene. 
3.1.4. Inheritance and stability of inserted DNA 
Genetic stability of the T304-40 insert was studied by Southern analysis. The tested samples 
represented four generations and a variety of genetic backgrounds and cultivation environments. The 
restriction enzyme–probe combinations used were sufficient to conclude that a single-copy insert 
together with its flanking regions was retained over several generations, indicating stability.
16
 
Supporting evidence for the phenotypic stability was obtained by segregation analysis of samples from 
two generations of plants with three different backgrounds. The results supported the presence of a 
single genetic locus, showing Mendelian segregation. 
3.2. Conclusion 
The molecular characterisation data establish that cotton T304-40 contains a single insertion locus 
consisting of partial copies of the cry1Ab and bar expression cassettes. Up-to-date bioinformatic 
analyses of the ORFs spanning the junction sites within the insert or between the insert and genomic 
DNA did not identify hazards. The stability of the inserted DNA and the introduced traits, namely the 
insect resistance and the herbicide tolerance, were confirmed over several generations. The potential 
impacts of the Cry1Ab and PAT protein levels, quantified in field trials carried out in the USA and in 
Spain, are assessed in the food/feed and environment sections. 
4. Comparative analysis 
4.1. Evaluation of the relevant scientific data 
The GMO Panel has considered the data on the compositional, agronomic and phenotypic 
characteristics of cotton T304-40 and its comparators as provided in the dossier and summarised 
below. 
                                                     
15 Technical Dossier/Section D3 (a), (b) and (d) 
16 Technical Dossier/Section D5 
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4.1.1. Choice of comparator and production of material for the comparative analysis17 
Field trials for the analysis of composition and agronomic and phenotypic characteristics of cotton 
T304-40 and its conventional counterpart were carried out at various locations in the USA during one 
season (2007)
18
 and the EU during two seasons (2007 and 2008).
19
 The conventional counterpart in 
these field trials was Coker 315, which has a similar genetic background to cotton T304-40. 
The eight field trials in the USA in 2007 were performed in Louisiana (two sites), Mississippi (two 
sites) and Texas (four sites), and included cotton T304-40 treated twice with glufosinate ammonium-
based herbicides during the growing season, cotton T304-40 treated with maintenance 
herbicides/pesticides (but not with glufosinate ammonium) and plots with the conventional counterpart 
treated with maintenance herbicides/pesticides. In each location the field trial had a complete 
randomised block design with three replications of each treatment. Fuzzy seed samples were harvested 
from each plot and ginned before further dispatch and handling for compositional analysis.
20
 
In the EU field trials were carried out in Spain in 2007 and 2008 in the regions of Catalonia
21
 (12 sites 
in 2007, eight sites in 2008) and of south Andalusia
22
 (six sites in 2008). In the Catalonian locations, a 
complete randomised block design with three replications and three treatments was conducted: cotton 
T304-40 treated twice with glufosinate ammonium-based herbicides; cotton T304-40 treated with 
maintenance herbicides; and the conventional counterpart treated with maintenance herbicides. In 
addition, two commercial reference varieties (Celia, Flora) were planted in each location, in single 
non-replicated plots in both years. In Andalusia, the same experimental design was followed, except 
that the commercial varieties included were different (Alexandro, Crema 111, Hermes) and a total of 
six field trials were planted with five replicates for each cotton line (T304-40 treated with glufosinate 
ammonium-based herbicide and T304-40, Coker 315 and commercial lines untreated with glufosinate 
ammonium-based herbicide). After harvest, fuzzy seed were ginned locally before further handling. 
Compositional analysis was performed on seed from eight Catalonian locations in 2007, and six 
Andalusian and two selected Catalonian locations in 2008. 
During both years of cultivation and at all field trial sites, various studies were carried out for the 
analysis of agronomic and phenotypic traits. 
4.1.2. Compositional analysis23 
The compounds analysed in cotton seeds followed the recommendations of OECD (2009). Harvested 
cotton seeds were analysed for proximates (protein, fat, ash, moisture and carbohydrate by 
calculation), fibre fractions (acid detergent fibre (ADF), neutral detergent fibre (NDF) and crude fibre 
(CF)), amino acids, fatty acids, vitamin E, minerals (calcium, phosphorus, potassium, magnesium, iron 
and zinc) and anti-nutrients (gossypol and cyclopropenoid fatty acids). 
The statistical analysis was an overall-site analysis of variance (ANOVA) to compare the conventional 
counterpart sprayed with required maintenance pesticides and cotton T304-40 sprayed with either 
glufosinate ammonium or required maintenance herbicides only. The ANOVA results indicated a 
statistically significant interaction between treatment and site for many parameters. For these 
parameters, the applicant performed t-tests comparing cotton T304-40 (sprayed or non-sprayed with 
glufosinate ammonium) with its conventional counterpart for each site separately. 
The statistical analysis of the compositional data of cotton seeds harvested from field trials in the USA 
in 2007 identified 16 statistically significant differences between cotton T304-40 sprayed with 
                                                     
17 Technical dossier/Section D7.2 
18 Technical dossier/Mackie (2008) 
19 Technical dossier/Villagran (2008) 
20 Technical dossier/Oberdörfer (2009a) 
21 Technical dossier/Villagran (2008, 2009b) 
22 Technical dossier/Villagran (2009a) 
23 Technical dossier/D7.3 
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required maintenance pesticides and the conventional counterpart Coker 315 and 18 statistically 
significant differences between cotton T304-40 treated with glufosinate ammonium and the 
conventional counterpart Coker 315 sprayed with maintenance pesticides (untreated) (Appendix 1, 
Table 1). 
The applicant initially performed a joint analysis of the compositional data from cotton seeds 
harvested from the EU field trials in 2007 and 2008. Upon request from the EFSA GMO Panel, the 
applicant analysed the data from the two years separately. 
The analysis of data from the EU in 2007 identified 17 statistically significant differences between 
cotton T304-40 sprayed with required maintenance pesticides (untreated) and the conventional 
counterpart Coker 315, and 13 statistically significant differences between cotton T304-40 treated with 
glufosinate ammonium and the conventional counterpart Coker 315 (Appendix 1, Table 2). 
The analysis of the EU 2008 field trial identified 18 statistically significant differences between T304-
40 sprayed with required maintenance pesticides and the conventional counterpart Coker 315 and 19 
statistically significant differences between T304-40 treated with glufosinate ammonium and the 
conventional counterpart Coker 315 (Appendix 1, Table 3). 
The level of calcium, zinc, linoleic acid, palmitic acid and stearic acid showed statistically significant 
differences in cotton T304-40 and Coker 315 over all three seasons of field trials and both treatment 
regimes with herbicides. However, the endpoint values for calcium, zinc, palmitic acid and stearic acid 
were within the limits of the reference varieties used in the European field trials in 2007 and 2008. The 
values for linoleic acid in both T304-40 and Coker 315 were higher than the range in values of the 
reference varieties in the European field trials in 2007, but within the range set by the reference 
varieties in the field trials in 2008. 
Having considered the total set of compositional data supplied and the observed compositional 
differences between cotton T304-40 and its conventional counterpart Coker 315, the nature and 
magnitude of the differences and biological variation, the EFSA GMO Panel concludes that no 
biologically relevant differences were identified in the compositional characteristics of seeds produced 
by cotton T304-40 compared with its conventional counterpart Coker 315, and that its composition 
falls within the range of estimated natural variation, except for the expression of the Cry1Ab and PAT 
proteins. 
4.1.3. Agronomic and phenotypic characteristics24 
Based on data collected at eight field trial sites in Spain in 2007 and 2008, the applicant performed a 
comparative assessment of the phenotypic and agronomic characteristics of cotton T304-40 and its 
conventional counterpart (Coker 315). The phenotypic and agronomic characteristics evaluated were 
plant height at maturity, number of developed nodes, presence and development of the fruiting organ 
at the first position on each node, seed cotton yield, stand count, fibre yield, number of seed per 10 
bolls, weight of fuzzy seed per 10 bolls, number of days to first flower, number of days to first boll, 
susceptibility to fungi, first fruiting branch, number of living insect larvae on immature blooms, 
flowers and bolls (analysed at two dates), number of immature blooms, flowers and bolls damaged by 
insects (analysed at two dates), fibre fineness (micronaire), fibre length, fibre length uniformity, short 
fibre index, fibre strength and fibre elongation. 
The applicant analysed the data using ANOVA, which identified statistically significant differences 
between cotton T304-40 and its conventional counterpart for the endpoints stand count, first fruiting 
branch, fibre yield, number of seeds per 10 bolls, weight of fuzzy seed per 10 bolls, number of days to 
first boll, number of flowers damaged by insects at date 1, number of bolls damaged by insects at date 
                                                     
24 Technical dossier/D7.4 
 Scientific Opinion on genetically modified cotton T304-40 
 
 EFSA Journal 2013;11(6):3251 13 
2, number of living larvae on bolls at both dates, fibre length uniformity, short fibre index and fibre 
strength. 
The differences for insect damage and presence of insect larvae were expected, as cotton T304-40 
expresses the insecticidal Cry1Ab protein. All the other statistically significant differences were within 
the natural variation of reference varieties. The differences in fibre parameter such as length, strength 
and micronaire did not lead to a different classification of the fibre quality. Based on the data 
presented by the applicant, the agronomic and phenotypic characteristics of insect-resistant and 
glufosinate ammonium-tolerant cotton event T304-40 are comparable to those of its conventional 
counterpart, Coker 315, and to the commercial non-GM cotton reference varieties grown in the same 
field trials. 
4.2. Conclusion 
Based on the information available, the EFSA GMO Panel concludes that no biologically relevant 
differences were identified in the composition, agronomic and phenotypic characteristics of plants and 
seeds obtained from cotton T304-40 that would require further assessment. 
5. Food/feed safety assessment 
5.1. Evaluation of relevant scientific data 
5.1.1. Effects of processing25 
The newly expressed proteins (Cry1Ab and PAT) were detectable in delinted seeds, cotton seed meal 
and hulls but non-detectable in crude and food grade oil of the GM cotton T304-40 in materials 
harvested from the USA field trial in 2009; they were present in toasted meal at very low levels. PAT 
was present in cotton seed and kernels; undetectable in refined oil; and either present at low levels or 
non-detectable in hulls and toasted meal, in all three years.
26
 Considering the toxicological profile and 
allergenic properties (see sections 5.1.2 and 5.1.3), the presence of Cry1Ab and PAT protein in 
derived products obtained through seed processing would not raise safety concern. 
Since no biologically relevant differences were identified in the composition, agronomic and 
phenotypic characteristics of plants and seeds obtained from cotton T304-40, the effect of processing 
on cotton T304-40 is not expected to be different from that on conventional cotton. 
5.1.2. Toxicology27 
5.1.2.1. Protein used for safety assessment 
Given the low levels of expression of the proteins Cry1Ab and PAT in tissues of cotton T304-40 
(below the level of quantification in seed, see section 3.1.3) and the difficulty of producing sufficient 
amounts for safety testing, recombinant Cry1Ab and PAT proteins produced in E. coli were used for 
safety testing. The structural and functional equivalence of bacterially produced Cry1Ab and PAT 
proteins to those expressed in cotton T304-40 was investigated with SDS-PAGE, western blotting, 
glycosylation analysis, N-terminal sequence analysis and mass spectrometry. These studies indicated 
that there were small differences between the plant-derived and microbial Cry1Ab proteins in both the 
N- and C-termini. However, there were no differences in insecticidal properties (Cry1Ab) or 
enzymatic activity (PAT) between the plant-derived and microbial proteins.
28
 Therefore, the GMO 
Panel accepts the use of the Cry1Ab and PAT proteins expressed in bacteria for the safety testing of 
the Cry1Ab and PAT proteins present in cotton T304-40. 
                                                     
25 Technical dossier/Section D7.1.6 
26 Technical dossier/Mackie (2009) 
27 Technical dossier/Section D7.2 
28 Technical dossier/Section D7.8.1.iv. 
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5.1.2.2. Toxicological assessment of newly expressed proteins in cotton T304-40 
The EFSA GMO Panel has previously evaluated the safety of the PAT protein in the context of several 
applications for the placing on the EU market of GM crops expressing PAT, and no concerns were 
identified (e.g. EFSA, 2005a, b, 2006b, 2007a, b, c, 2008, 2011c, 2012a). 
There is a considerable body of knowledge on Cry1Ab, including in vivo, in vitro and in silico studies, 
which does not indicate safety concerns (EFSA, 2005b, 2009b, c, 2012b, c). The results of the updated 
bioinformatic analysis provided in the context of this application do not change these conclusions.
29
 In 
the context of this application the applicant has provided an acute toxicity of Cry1Ab in mice and in 
vitro digestibility studies of Cry1Ab and PAT proteins newly expressed by cotton T304-40. 
(a) Acute oral toxicity testing 
The Cry1Ab protein was administrated by oral gavage at a dose of 2 000 mg/kg body weight to a 
single group of five female mice. One animal died for reasons considered unrelated to treatment. No 
treatment-related adverse effects were observed.
30
 
The EFSA GMO Panel is of the opinion that acute toxicity testing of the newly expressed proteins is 
of little additional value for the risk assessment of the repeated consumption of food and feed from 
GM plants by humans and animals. 
(b) Bioinfomatic studies
31
 
Bioinformatic analyses of the amino acid sequences of the Cry1Ab and PAT proteins expressed in 
cotton T304-40 revealed no significant similarities to known toxic proteins. 
(c) Resistance to degradation by proteolytic enzymes
32
 
The resistance to degradation by pepsin of the Cry1Ab protein was measured in solutions at pH 1.2. 
The integrity of the test protein in samples of the incubation mixture taken at various time points was 
analysed by gel electrophoresis followed by protein staining. No Cry1Ab protein was detected within 
two minutes of incubation. 
The resistance to degradation by pancreatin of the Cry1Ab protein was also assessed in solutions at pH 
7.5. Stable fragments of different molecular weight of the Cry1Ab protein were observed at different 
time points. The EFSA GMO Panel notes that this study is not required by either EFSA guidance 
documents (EFSA, 2006a, 2011a) or Codex Alimentarius (2009). 
Published data showed that a bacterially produced analogue of the PAT protein encoded by the bar 
gene is degraded by pepsin within 30 seconds and by pancreatin within five minutes (Hérouet et al., 
2005). As previously mentioned, the resistance to degradation by pancreatin study is not required by 
international guidelines (EFSA, 2006a, 2011a; Codex Alimentarius, 2009). 
5.1.2.3. Animal studies with the food/feed derived from GM plants 
(a) Sub-chronic toxicity study
33
 
In a sub-chronic, 13-week feeding study, groups of 10 male and 10 female rats (strain Wistar Rj:WI 
(IOPS HAN)) received diets containing toasted cotton T304-40 seed meal at 5 % (supplemented with 
                                                     
29 Technical dossier/Section D7.8, Additional information, May 2013 
30 Technical dossier/Section D7.8.1 
31 Technical dossier/Section D7.8, Additional information, May 2013 
32 Technical dossier/Section D7.8.1.i 
33 Technical dossier/Section D7.8.1.iii 
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5 % Coker 315 cotton) and 10 % inclusion level, the conventional counterpart Coker 315 (inclusion 
level 10 %) or the commercial non-GM control FM958. 
Animals were housed in cages with five rats of the same sex per cage, but the data analysis considered 
the individual animal as the experimental unit, ignoring a possible bias due to cage interactions. As the 
cage should be considered the experimental unit and because of the low number of experimental units 
per treatment (two per sex), a statistical analysis of the data is not possible. 
(b) Chicken feeding study 
Zootechnical parameters of chicken for fattening fed diets (starter first week, grower second and third 
week, finisher until end) containing 10 % toasted cotton seed meal each prepared from the GM cotton 
T304-40, the conventional counterpart (Coker 315) and one commercial non-GM cotton variety 
(FM958), respectively, for 42 days were compared.
34
 A total of 420 one-day-old chicken (ROSS 308, 
half male and half female) broiler chicks were randomly assigned to one of the three treatments, each 
treatment consisting of 14 replicate pens (seven pens per sex, 10 birds per pen). The diets containing 
approximately 10 % of toasted cotton seed meal were formulated to meet poultry nutrient 
requirements under typical local industry husbandry and to be isonitrogenous, isocaloric and balanced 
for sulphur and limiting amino acids (analytically confirmed). Diets with the cotton T304-40 seed 
meal, but not the control diets or the reference diets, contained the cry1Ab gene. 
Effects on health, survival, live weight, total weight gain, feed consumption, feed to gain ratio, 
marketable carcass weight and muscle tissue weight and yield (breast, thigh, leg, wing) and abdominal 
fat pad weight were compared among groups. Body weight, weight gain, feed intake and feed to gain 
ratio were measured or calculated at weekly intervals until the end of the trial. 
Statistical evaluation was carried out by ANOVA using the pen as the experimental unit for survival, 
feed consumption and feed to gain ratio, and using the individual bird measurements for the other 
parameters. 
Overall mortality/cull was 10.5 % (44 birds). Post-mortem analysis showed ascites for 35 birds, and 
petechia in the lung or haemorrhages in the lung or respiratory tract for the others. Deaths were not 
treatment related. 
The final body weight was 2.75 kg in the T304-40 group, 2.78 kg in the Coker 315 group and 2.82 kg 
in the FM958 group. The cumulative feed to gain ratio was 1.83 in the T304-40 group, 1.80 in the 
Coker 315 group and 1.78 in the FM 958 group. No significant differences were found for final body 
weight, weight gain, feed intake or feed to gain between the groups. As expected, females had a lower 
body weight, consumed less feed and showed a higher feed to gain ratio than males. A statistically 
significant treatment  sex interaction was observed for feed consumption but not for feed to gain 
ratio. At study termination the subset of 42 randomly selected birds/treatment processed (three birds 
per cage) for carcass and tissue weights was examined for gross pathology. Two abnormal 
observations (both in the T304-40 group: one male with ascites, congested intestines and enlarged 
heart and liver, and one female with pericarditis and perihepatitis) were made at this time. Of the 
remaining birds, carcass characteristics were not significantly different between groups. There was no 
significant treatment by sex interaction. 
Since all diets were designed to deliver the same nutrition, the expectation was that birds in the three 
groups would show essentially the same performance characteristics. The results confirmed the 
nutritional value of the cotton T304-40 seed and the absence of any unintended effects able to impact 
on growth at the level tested. Having considered the design and outcome of the feeding study with 
chicken for fattening, the Panel notes that the value of the study is limited by (i) the high mortality 
observed and (ii) the low dietary inclusion level of cotton seed. 
                                                     
34 Technical dossier/Section D7.8.4, Study report M-350594-02-1 (2010) 
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5.1.3. Allergenicity35 
The strategies used when assessing the potential allergenic risk focus on the characterisation of the 
source of the recombinant protein, the potential of the newly expressed protein to induce sensitisation 
or to elicit allergic reactions in already sensitised persons and whether the transformation may have 
altered the allergenic properties of the modified plant. 
5.1.3.1. Assessment of allergenicity of the newly expressed protein 
A weight-of-evidence approach is followed, taking into account all of the information obtained with 
various test methods, since no single experimental method yields decisive evidence for allergenicity 
(EFSA, 2006a, 2011a; Codex Alimentarius, 2009). 
The cry1Ab gene originates from B. thuringensis subsp. kurstaki, a soil microorganism that is not 
known to be allergenic. The source of the bar gene encoding for the PAT protein is S. hygroscopicus, 
which is also a soil microorganism that is not known to be allergenic. 
In the current application (EFSA-GMO-NL-2011-97), updated bioinformatic analyses
36
 of the amino 
acid sequences of the Cry1Ab and PAT proteins using the criterion of 35 % identity in a window of 80 
amino acids revealed no significant similarities to known allergens. In addition, the applicant 
performed analyses
22
 searching for matches of eight contiguous identical amino acid sequences 
between the Cry1Ab and PAT proteins and known allergens, which confirmed the outcome of the 
previous bioinformatic analyses. 
The studies on resistance to degradation of Cry1Ab and PAT proteins by proteolytic enzymes have 
been described in section 5.1.2.2. 
The EFSA GMO Panel has previously evaluated the safety of the Cry1Ab and/or PAT protein in the 
context of several applications and no concerns on allergenicity were identified (e.g. EFSA, 2005a, b, 
2006b, 2007a, b, c, 2008, 2009b, c, 2010b, 2011c, 2012a, b, c). 
Based on the available information, the EFSA GMO Panel considers that there are no indications that 
the newly expressed Cry1Ab and PAT proteins in cotton T304-40 may be allergenic. 
5.1.3.2. Assessment of allergenicity of the whole GM plant 
According to the guidance documents of the Scientific Panel on Genetically Modified Organisms for 
the risk assessment of food and feed derived from genetically modified plants (EFSA, 2006a, 2011a), 
when the plant receiving the introduced gene is known to be allergenic, the applicant should test any 
potential change in the allergenicity of the whole GM plant by comparing the allergen repertoire with 
that of its appropriate comparator(s). 
Cotton has not been considered to be a common allergenic food
37
 and only a few cases of food allergy 
to cotton seed have been reported (Atkins, 1988; Malanin and Kalimo, 1988; O‟Neil and Lehrer, 
1989), all of which were to foods with cotton seed flour as the offending ingredient. Cotton seed 
protein appears to contain allergen(s) of relevant potency. However, the main cotton seed product in 
human food, industrially processed cotton seed oil, is highly purified and contains negligible levels of 
proteins. Also in cellulose from cotton seed linters for use as food or food ingredient, the protein level 
is considered to be very low. 
                                                     
35 Technical dossier/Section D7.9 
36 Additional information, May 2013 
37 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to 
Directive 2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ, L310, 11–14. 
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In the context of the present application and based on the available information, the EFSA GMO Panel 
considers that there is no evidence that the genetic modification might significantly change the overall 
allergenicity of cotton T304-40. 
5.1.4. Nutritional assessment of food/feed derived from GM plants 
The intended trait of cotton T304-40 is insect resistance and herbicide tolerance, with no intention to 
alter the nutritional parameters. The outcome of the composition analysis (see section 4.1.2) confirmed 
the nutritional equivalence of the food and feed products derived from cotton T304-40. The 
introduction of these products into the food and feed chain is, therefore, expected to have no 
nutritional impact, as compared with its conventional counterpart and non-GM cotton varieties. 
The compositional data indicated nutritional equivalence between the GM cotton T304-40 and 
commercial non-GM cotton varieties (see section 4.1.2). Owing to limitations in the feeding study in 
broilers, these results could not be confirmed (see section 5.1.2.3.b). Nevertheless, in accordance with 
the EFSA guidance document (EFSA, 2006a, 2011a), the EFSA GMO Panel concludes that cotton 
T304-40 is as nutritious as other cotton varieties commercially available. 
5.1.5. Post-market monitoring of GM food/feed 
No biologically relevant compositional, agronomic and phenotypic changes were identified in cotton 
T304-40 when compared with its conventional counterpart and commercial cotton varieties. 
Furthermore, the overall intake or exposure is not expected to change because of the introduction of 
cotton T304-40 into the market. The EFSA GMO Panel therefore considers cotton T304-40 to be as 
safe as its conventional counterpart and that post-market monitoring (EFSA, 2006a, 2011a) of the 
food/feed derived from cotton T304-40 is not necessary. 
5.2. Conclusion 
The safety assessment identified no concerns regarding the potential toxicity and allergenicity of the 
newly introduced Cry1Ab and PAT proteins. Based on the information available, there is no evidence 
that the genetic modification might significantly change the overall allergenicity of cotton T304-40. 
Nutritional equivalence of cotton T304-40 to its conventional counterparts was indicated by 
compositional data. The EFSA GMO Panel concludes that cotton T304-40 is as safe and nutritious as 
its conventional counterpart and that it is unlikely that the overall allergenicity of the whole plant is 
changed. 
6. Environmental risk assessment and monitoring plan 
6.1. Evaluation of relevant scientific data 
The scope of application EFSA-GMO-NL-2011-97 is for food and feed uses, import and processing 
and does not include cultivation. Considering the intended uses of cotton T304-40, the environmental 
risk assessment is concerned with indirect exposure, mainly through ingestion by animals, and their 
manure and faeces leading to exposure of gastrointestinal tract and soil microorganisms, and with the 
accidental release into the environment of viable cotton T304-40 seeds (e.g. during transport and/or 
processing). 
Cotton T304-40 has been developed for tolerance to glufosinate ammonium-based herbicides and 
protection against certain lepidopteran pests such as cotton bollworm larvae and tobacco budworm 
larvae. Herbicide tolerance is conferred by the expression of the PAT protein. Insect resistance is 
achieved by the expression of the B. thuringiensis-derived Cry1Ab protein. As the scope of the present 
application excludes cultivation, environmental concerns in the EU related to the use of glufosinate 
ammonium-based herbicides on the GM cotton do not apply. 
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6.1.1. Environmental risk assessment 
6.1.1.1. Unintended effects on plant fitness due to the genetic modification38 
Gossypium hirsutum is highly domesticated crop which has been grown in southern Europe since the 
nineteenth century, giving rise to feral plants which can occasionally be found in the same area 
(Todaro, 1917; Davis, 1967). In the EU,
39
 cotton is cultivated in Greece and Spain, and there is about 
700 hectares in Bulgaria (USDA, 2009). The main cultivated cotton (G. hirsutum), which has been 
present in southern Europe since the nineteenth century, is an annual self-pollinating crop. In the 
absence of insect pollinators (such as wild bees, honeybees, bumblebees), cotton flowers are self-
pollinating, but when these pollinators are present low frequencies of cross-pollination can occur 
(McGregor, 1959; Moffett and Stith, 1972; Moffett et al., 1975; Van Deynze et al., 2005). 
Pollen and seed dispersal by cotton are potential sources of vertical gene flow to cross-compatible 
wild cotton relatives, other cotton varieties and occasional feral cotton plants. However, in Europe, 
there are no cross-compatible wild relatives with which cotton can hybridise. Because cotton pollen is 
very large (120–200 µm), heavy and sticky, wind-mediated dispersal of pollen to other cotton varieties 
is considered negligible (Vaissiere and Vinson, 1994). In addition, cross-pollination percentages 
steeply decrease with increasing distance from the pollen source (Umbeck et al., 1991; Kareiva et al., 
1994; Llewellyn and Fitt, 1996; Xanthopoulos and Kechagia, 2000; Van Deynze et al., 2005, 2011; 
Zhang et al., 2005; Hofs et al., 2007; Llewellyn et al., 2007; Heuberger et al., 2010). 
Seeds are the only survival structures. However, seed-mediated establishment of cotton and its 
survival outside of cultivation in Europe is mainly limited by a combination of absence of a dormancy 
phase, low competitiveness and susceptibility to diseases and cold climate conditions (Eastick and 
Hearnden, 2006). In regions where cotton is widely grown, such as Australia, the risk of GM cotton 
becoming feral along transportation routes, or a weed on dairy farms where raw cotton seed is used as 
feed, has been shown to be negligible (Addison et al., 2007). Since the general characteristics of cotton 
T304-40 are unchanged relative to its conventional counterpart, the inserted insect resistance trait is 
not likely to provide a selective advantage outside of cultivation in Europe. If accidental spillage and 
subsequent release into the environment of cotton T304-40 seeds occurs, cotton T304-40 plants would 
have a selective advantage only under conditions of high infestation by susceptible Lepidopteran 
species or application of glufosinate ammonium-based herbicides which are not commonly used on 
cultivated cotton or in most areas where the GM cotton might be spilled. Insect resistance against 
certain lepidopteran pests, such as cotton bollworm (CBW, Helicoverpa armigera), pink bollworm 
(PBW, Pectinophora gossypiella) and tobacco budworm (TBW, Heliothis virescens) provides a 
potential advantage in cultivation under infestation conditions, but plant survival is also limited by 
sensitivity to a range of other environmental factors. It is thus considered very unlikely that cotton 
T304-40 or its progeny will differ from other cotton varieties in their ability to survive until 
subsequent seasons or establish feral populations under European environmental conditions. 
Field trials with cotton T304-40 were carried out by the applicant across 12 locations in Spain in 2007 
and across 14 locations in Spain in 2008, as described in section 4.1.1. In several Catalonian locations 
(three in 2007, two in 2008) and two Andalusian locations (in 2008), fuzzy seeds of T304-40 and 
Coker 315 were re-sown after harvest to assess their potential overwintering capacity. 
As mentioned above, the combined site analysis of the 2007 and 2008 field data identified statistically 
significant differences between treated and untreated cotton T304-40 and the conventional counterpart 
in the first bolls position, plant emergence, seed number, seed weight, days until boll formation, 
damage to flowers (first observation date) and living larvae in bolls (both observation dates). 
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Considering the scope of the application, special attention is paid to those agronomic characteristics 
which may affect the survival, establishment and fitness of cotton T304-40 seeds which could be 
accidentally released into the environment: yield, plant height, shattering, germination and dormancy. 
None of the significant differences observed was indicative of a consistent plant response associated 
with the trait. The EFSA GMO Panel considers that the small differences observed are unlikely to 
affect the overall fitness, invasiveness or weediness of the GM cotton. 
In addition to the data presented by the applicant, the EFSA GMO Panel is not aware of any scientific 
report of increased fecundity, persistence (volunteerism) or ferality of GM cotton in regions where it is 
cultivated (Eastick and Hearnden, 2006; Bagavathiannan and Van Acker, 2008). There is no 
information to indicate change in survival capacity (including over-wintering). 
Furthermore, there is no evidence that the traits introduced by the genetic modification result in 
increased persistence and invasiveness of a crop species. Thus, escaped plants and genes dispersed to 
other cotton plants would result in plant populations no different from existing populations and would 
not create additional agronomic or environmental impacts. 
The EFSA GMO Panel is of the opinion that the likelihood of unintended environmental effects of the 
cotton T304-40 in Europe will not be different from that of conventional cotton varieties. 
6.1.1.2. Potential for gene transfer40 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
through either horizontal gene transfer of DNA or vertical gene flow via seed dispersal and cross-
pollination. 
(a) Plant-to-bacteria gene transfer 
Genomic DNA is a component of many food and feed products derived from cotton. It is well 
documented that DNA present in food and feed becomes substantially degraded during processing and 
digestion in the human or animal gastrointestinal tract. However, a low level of exposure of fragments 
of ingested DNA, including the recombinant fraction of such DNA, to bacteria in the digestive tract of 
humans, domesticated animals and other environments exposed to the GM plant or plant material is 
expected. 
Current scientific knowledge of recombination processes in bacteria indicates that horizontal transfer 
of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as plants 
to microorganisms) is not likely to occur at detectable frequencies under natural conditions (see EFSA, 
2009a, for further details). 
A successful horizontal transfer would require stable insertion of the transgene sequences into a 
bacterial genome and a selective advantage conferred to the transformed host. The only mechanism 
known to facilitate horizontal transfer of non-mobile, chromosomal DNA fragments to bacterial 
genomes is homologous recombination. This requires the presence of stretches of DNA sequences that 
are similar in the recombining DNA molecules and, in addition to substitutive gene replacement, 
facilitates the insertion of non-homologous DNA sequences if their flanking regions share sequence 
similarity with bacterial sequences in the recipient. 
Cotton T304-40 contains genetic elements with identity or high similarity to those of bacteria. These 
are the coding sequence of Cry1Ab, a codon-optimised sequence of cry1Ab from B. thuringiensis, and 
the coding sequence of the phosphinothricin acetyltransferase (bar) gene of Streptomyces 
hygroscopicus. The flanking regions of the recombinant gene insert contain approximately 20-bp-long 
sequences of the truncated right and left border of the Ti plasmid of A. tumefaciens. Both species, B. 
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thuringiensis and S. hygroscopicus, are not considered to be prevalent in the main receiving 
environment, i.e. the gastrointestinal tract of humans or animals. Both occur in soil and, in addition, 
B. thuringiensis has been frequently isolated from the guts of insects (Jensen et al., 2003). However, 
occurrence of the recombinant genes outside their immediate receiving environment in the habitats of 
both bacterial species cannot be ruled out (Hart et al., 2009) and is therefore also considered here. 
On a theoretical basis (i.e. in the absence of experimental evidence of horizontal gene transfer in GM 
food and feed derived from cotton T304-40 or any other GM plant), it can be assumed that, as an 
extremely rare event, homologous recombination may occur in the environment between the 
recombinant cry1Ab or bar genes and their natural variants as they may occur in B. thuringiensis (for 
cry1Ab) and S. hygroscopicus (for bar) or other bacteria. Such recombination events would replace 
only natural variants (i.e. substitutive recombination) and are therefore unlikely to provide any new 
property connected to a selective advantage for the recipient organisms (EFSA, 2009a). Double 
homologous recombination of the flanking regions with those on Ti plasmids of A. tumefaciens would 
result in gene replacement, by which a cry1Ab-bar gene construct would substitute genes for crown 
gall formation (loss of auxin-, cytokinin- and opine-synthesising genes). However, the current 
literature suggests a minimal length of approximately 150 bp of homologous DNA to facilitate 
recombination (De Vries and Wackernagel, 2002). Therefore, the 20-bp flanking regions of the Ti-
plasmid can probably not be considered to contribute to a horizontal gene transfer of the recombinant 
gene to natural strains of Agrobacterium with Ti plasmids. 
In addition to homology-based recombination processes, illegitimate recombination that does not 
require similarity between the recombining DNA molecules is theoretically possible. However, the 
transformation rates for illegitimate recombination are considered to be 10
10
-fold lower than for 
homologous recombination (Hülter and Wackernagel, 2008; EFSA, 2009a). Illegitimate recombination 
events have not been detected even in studies that have exposed bacteria to high concentrations of GM 
plant DNA (EFSA, 2009a). 
The cry1Ab and bar genes of T304-40 are regulated by promoters of the Subterranean clover stunt 
virus or the Cauliflower mosaic virus, respectively. The expression of the Ps7s7-cry1Ab and p35S3-
bar constructs in bacteria is unknown, but generally the expression level of eukaryotic promoters in 
bacteria is inefficient (Warren et al., 2008). 
The EFSA GMO Panel concludes that the cry1Ab or bar genes from cotton T304-40 may, on a 
theoretical basis, replace natural variants (substitutive recombination) and are therefore unlikely to 
provide any new property connected to a selective advantage for the recipient organisms. Considering 
its intended uses as food and feed and the above assessment, the EFSA GMO Panel has not identified 
any concern associated with horizontal gene transfer from cotton T304-40 to bacteria. 
(b) Plant-to-plant gene transfer 
Considering the intended uses of cotton T304-40 and the physical characteristics of cotton seeds, a 
possible pathway of dispersal is from seed spillage and pollen of occasional feral GM cotton plants 
originating from accidental seed spillage during transportation and/or processing. 
The genus Gossypium consists of at least four species: G. arboreum, G. barbadense, G. herbaceum 
and G. hirsutum. G. herbaceum is reported to be a traditional fibre crop in the eastern Mediterranean 
area already in the pre-Columbus period (before 1500 AD) (Zohary and Hopf, 2000). In southern 
Europe, G. herbaceum and G. hirsutum have been grown since the nineteenth century giving rise to 
occasional feral plants in the same area (Davis, 1967; Tutin et al., 1992) but no sexually compatible 
wild relatives of G. hirsutum have been reported in Europe. Therefore, the plant-to-plant gene transfer 
from this GM cotton is restricted to cultivated and occasional feral populations. 
Insect resistance against certain lepidopteran pests, such as European cotton bollworm (CBW, 
Helicoverpa armigera), pink bollworm (PBW, Pectinophora gossypiella) and tobacco budworm 
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(TBW, Heliothis virescens), provides an advantage in cultivation under infestation conditions. 
Survival of cotton outside cultivation in Europe is mainly limited by a combination of low 
competitiveness, absence of a dormancy phase and susceptibility to diseases and cold climatic 
conditions. Since these general characteristics of this GM cotton are unchanged, the inserted traits are 
not likely to provide a selective advantage outside of cultivation in Europe. 
The EFSA GMO Panel also takes into account the fact that this application does not include 
cultivation of the GM cotton T304-40 within the EU so that the likelihood of cross-pollination 
between the imported GM cotton T304-40 and cotton crops and occasional feral cotton plants is 
considered to be extremely low. Even in the case that feral populations of cotton T304-40 were 
established or transgene flow occurred to cultivated and feral cotton, a selective advantage would 
occur only under infestation of sensitive pest species or application of glufosinate ammonium-based 
herbicides. 
6.1.1.3. Interactions of the GM plant with target organisms41 
Owing to the intended uses of cotton T304-40, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions of the GM plant with target organisms were not 
considered an issue by the EFSA GMO Panel. 
6.1.1.4. Interactions of the GM plant with non-target organisms42 
Owing to the intended uses of cotton T304-40, which exclude cultivation, and as a result of the low 
level of exposure to the environment, potential interactions of the GM cotton with non-target 
organisms were not considered an issue by the EFSA GMO Panel. 
However, the EFSA GMO Panel evaluated whether the Cry1Ab protein might potentially affect non-
target organisms by entering the environment through manure and faeces from animals fed with this 
GM cotton. Owing to the specific insecticidal selectivity of Cry proteins, non-target organisms most 
likely to be affected by the Cry1Ab protein belong to a same or closely related taxonomic group as 
those of the target organisms. 
Cry proteins are degraded by enzymatic activity in the gastrointestinal tract, meaning that only low 
amounts of Cry proteins would remain intact to pass out in faeces. This was demonstrated for Cry1Ab 
(Einspanier et al., 2004; Lutz et al., 2005, 2006; Wiedemann et al., 2006; Guertler et al., 2008). There 
would subsequently be further degradation of these Cry proteins in the manure and faeces because of 
intrinsic microbial proteolytic activity. In addition, there would be further degradation of Cry proteins 
in soil, reducing the possibility for the exposure of potentially sensitive non-target organisms. 
Although Cry proteins may bind to clay minerals and humic substances in soil, thereby reducing their 
availability to microorganisms for degradation, there are no indications of persistence and 
accumulation of Cry proteins from GM crops in soil (reviewed by Icoz and Stotzky, 2008). The EFSA 
GMO Panel is not aware of evidence of released Cry proteins from GM plants causing significant 
negative effects on soil micro- or macroorganisms. Considering the scope of the application, it can be 
concluded that the exposure of potentially sensitive non-target organisms to the Cry1Ab protein is 
likely to be very low and of no biological relevance. 
6.1.1.5. Interaction with the abiotic environment and biogeochemical cycles43 
Owing to the intended uses of cotton T304-40, which exclude cultivation, and the low level of 
exposure to the environment, potential interactions with the abiotic environment and biogeochemical 
cycles were not considered an issue by the EFSA GMO Panel. 
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6.2. Post-market environmental monitoring44 
The objectives of a post-market environmental monitoring (PMEM) plan according to Annex VII of 
Directive 2001/18/EC are (1) to confirm that any assumption regarding the occurrence and impact of 
potential adverse effects of the GMO, or its use, in the environmental risk assessment are correct and 
(2) to identify the occurrence of adverse effects of the GMO, or its use, on human health or the 
environment which were not anticipated in the environmental risk assessment. 
Monitoring is related to risk management, and thus a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the monitoring plan provided by the applicant (EFSA, 2011b). The potential exposure to the 
environment of cotton T304-40 would be through ingestion by animals and their manure and faeces 
leading to exposure of gastrointestinal tract and soil microbial populations to recombinant DNA, and 
through accidental release into the environment of GM cotton seeds during transport and/or 
processing. The scope of the PMEM plan provided by the applicant is in line with the intended uses. 
As the environmental risk assessment did not cover cultivation and identified no potential adverse 
environmental effects, no case-specific monitoring is necessary. 
The PMEM plan proposed by the applicant includes (1) the description of an approach involving 
operators (federations involved in cotton import and processing) reporting to the applicant via a 
centralised system any observed adverse effect(s) of GMOs on human health and the environment; (2) 
a coordinating system established by EuropaBio for the collection of the information recorded by the 
various operators; and (3) the use of networks of existing surveillance systems (Lecoq et al., 2007; 
Windels et al., 2008). The applicant proposes to submit a PMEM report on an annual basis and a final 
report at the end of the consent. 
The EFSA GMO Panel is of the opinion that the scope of the PMEM plan proposed by the applicant is 
in line with the intended uses of cotton T304-40, as the environmental risk assessment did not cover 
cultivation and identified no potential adverse environmental effects. In addition, the EFSA GMO 
Panel acknowledges the approach proposed by the applicant to put in place appropriate management 
systems to restrict environmental exposure in the case of accidental release of viable seeds of cotton 
T304-40. The EFSA GMO Panel agrees with the reporting intervals proposed by the applicant in the 
PMEM plan. 
6.3. Conclusion 
The scope of application EFSA-GMO-NL-2011-97 is for food and feed uses, import and processing 
and does not include cultivation. Considering the intended uses of cotton T304-40, the environmental 
risk assessment is concerned with indirect exposure, mainly through ingestion by animals, and their 
manure and faeces leading to exposure of gastrointestinal tract and soil microorganisms, and with the 
accidental release into the environment of viable cotton T304-40 seeds (e.g. during transport and/or 
processing). In the case of accidental release into the environment of viable seeds of cotton T304-40, 
there are no indications of an increased likelihood of spread and establishment of feral cotton T304-40 
plants. Considering its intended uses as food and feed, interactions with the biotic and abiotic 
environment were not considered to be an issue. Risks associated with an unlikely but theoretically 
possible horizontal gene transfer from cotton T304-40 to bacteria have not been identified. The scope 
of the PMEM plan provided by the applicant and the reporting intervals are in line with the intended 
uses of cotton T304-40 and the guidance document of the EFSA GMO Panel on PMEM of GM plants 
(EFSA, 2011b). In addition, the EFSA GMO Panel acknowledges the approach proposed by the 
applicant to put in place appropriate management systems to restrict environmental exposure in cases 
of accidental release of viable seeds of cotton T304-40. The EFSA GMO Panel agrees with the 
reporting intervals proposed by the applicant in the PMEM plan. 
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CONCLUSIONS AND RECOMMENDATIONS 
The molecular characterisation data establish that the GM cotton T304-40 contains a single insert 
consisting of copies of the cry1Ab and the bar expression cassettes. No other parts of the plasmid used 
for transformation are present in cotton T304-40. Bioinformatic analyses and genetic stability studies 
did not raise safety issues. The levels of the Cry1Ab and PAT proteins in cotton T304-40 have been 
sufficiently analysed. 
The EFSA GMO Panel compared the composition, phenotypic and agronomic characteristics of cotton 
T304-40 with those of its conventional counterpart and assessed all statistically significant differences 
identified. The Panel came to the conclusion that no biologically relevant differences were identified 
in the composition or agronomic or phenotypic characteristics of cotton T304-40 as compared with its 
conventional counterpart, and that its composition falls within the range of estimated natural variation, 
except for the expression of the Cry1Ab and PAT proteins. The safety assessment of the newly 
expressed proteins and the whole crop included an analysis of data from analytical and bioinformatic 
studies, as well as in vitro and in vivo studies. Based on the information available, there is no evidence 
that the genetic modification might significantly change the overall allergenicity of cotton T304-40. 
As neither the molecular characterisation nor the compositional analysis of the GM cotton indicated 
unintended effects, an alteration in the toxicity properties of GM cotton seed appears to be unlikely. 
Nutritional equivalence of cotton T304-40 to its conventional counterparts was indicated by 
compositional data. The EFSA GMO Panel concludes that cotton T304-40 is as safe and nutritious as 
its conventional counterpart and that it is unlikely that the overall allergenicity of the whole plant is 
changed. 
Considering the intended uses of cotton T304-40, the environmental risk assessment is concerned with 
indirect exposure, mainly through ingestion by animals, and their manure and faeces leading to 
exposure of gastrointestinal tract and soil microorganisms, and with the accidental release into the 
environment of viable cotton T304-40 seeds (e.g. during transport and/or processing). In the case of 
accidental release into the environment of viable seeds of cotton T304-40, there are no indications of 
an increased likelihood of spread and establishment of feral cotton T304-40 plants. Considering its 
intended uses as food and feed, interactions with the biotic and abiotic environment were not 
considered to be an issue. Risks associated with an unlikely but theoretically possible horizontal gene 
transfer from cotton T304-40 to bacteria have not been identified. The scope of the PMEM plan 
provided by the applicant and the reporting intervals are in line with the intended uses of cotton T304-
40 and the guidance document of the EFSA GMO Panel on PMEM of GM plants (EFSA, 2011b). In 
addition the EFSA GMO Panel acknowledges the approach proposed by the applicant to put in place 
appropriate management systems to restrict environmental exposure in cases of accidental release of 
viable seeds of cotton T304-40. The EFSA GMO Panel agrees with the reporting intervals proposed 
by the applicant in the PMEM plan. 
In conclusion, the EFSA GMO Panel considers that the information available for cotton T304-40 
addresses the scientific issues indicated by the guidance document of the EFSA GMO Panel and the 
scientific comments raised by the Member States, and that cotton T304-40 is as safe as its comparator 
with respect to potential effects on human and animal health or the environment in the context of its 
intended uses. 
DOCUMENTATION PROVIDED TO EFSA 
1. Letter from the Competent Authority of The Netherlands received on 7 April 2011 concerning a 
request for placing on the market of cotton T304-40 for food and feed uses, import and processing 
in accordance with Regulation (EC) No 1829/2003. 
2. Acknowledgement letter dated 28 April 2011 from EFSA to the Competent Authority of The 
Netherlands. 
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3. Letter from EFSA to applicant dated 26 May 2011 requesting additional information under 
completeness check. 
4. Letter from applicant to EFSA received on 7 July 2012 providing the timeline for submission of 
responses. 
5. Letter from applicant to EFSA received on 29 August 2011 providing additional information 
under completeness check. 
6. Letter from EFSA to applicant dated 12 September 2011 requesting additional information under 
completeness check. 
7. Letter from applicant to EFSA received on 3 October 2011 providing additional information under 
completeness check. 
8. Letter from EFSA to applicant dated 24 October 2011 delivering the „Statement of Validity‟ for 
application EFSA-GMO-NL-2011-97, cotton T304-40 submitted by Bayer under Regulation (EC) 
No 1829/2003. 
9. Letter from EFSA to applicant dated 5 December 2011 requesting additional information and 
stopping the clock. 
10. Letter from applicant to EFSA received on 29 December 2012 providing the timeline for 
submission of responses. 
11. Letter from applicant to EFSA received on 22 March 2012 providing additional information. 
12. Letter from EFSA to applicant dated 23 April 2012 requesting additional information and 
maintaining the clock stopped. 
13. Letter from applicant to EFSA received on 6 June 2012 providing additional information. 
14. Letter from EFSA to applicant dated 9 January 2013 re-starting the clock. 
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APPENDIX 1. 
Table 1: Mean values for constituents in seeds of cotton T304-40 and its conventional counterpart 
Coker 315 harvested in the USA in 2007 (T304-40 treated or untreated with glufosinate ammonium) 
for which statistically significant differences were identified by the statistical analysis 
Component
1
 
T304-40 
 
Conventional counterpart 
Treated  Untreated  
Ash % 3.87 3.95 3.68 
Protein % 24.94 24.68 24.06 
NDF % 46.41 45.31 47.81 
Calcium % 0.184 0.187 0.144 
Iron mg/kg 44.1 47.1 42.0 
Magnesium % 0.363 0.366 0.338 
Phosphorus % 0.554 0.568 0.528 
Zinc mg/kg 35.6 36.3 31.7 
Myristic acid % rel. 0.65 0.66 0.76 
Palmitic acid % rel. 23.40 23.40 24.12 
Palmitoleic acid % rel. 0.43 0.44 0.48 
Stearic acid % rel. 2.76 2.71 2.48 
Linoleic acid % rel. 57.14 56.96 56.18 
α-Linolenic acid % rel. 0.22 NS 0.21 
Arachidic acid % rel. 0.287 0.286 0.291 
Lignoceric acid % rel. < 0.12–0.12 < 0.12–0.13 < 0.12–0.24 
Dihydrosterculic acid % rel. 0.138 NS 0.159 
Phytic acid % 1.49 1.51 1.38 
1 Components for which statistically significant differences were identified between T304-40 (treated or untreated) and the 
conventional counterpart are shown. For components where statistically significant treatment  site interactions were seen, 
significance was considered to exist when a majority (> 50 %) of the sites showed a statistically significant difference when 
analysed separately. Fatty acids are in % relative to all fatty acids. NS, not statistically significant. 
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Table 2: Mean values for constituents in seeds of cotton T304-40 and its conventional counterpart 
Coker 315 harvested in the EU in 2007 (T304-40 treated or untreated with glufosinate ammonium) for 
which statistically significant differences were identified by the statistical analysis 
Component
1
 
T304-40 
 
Conventional 
counterpart  
Reference 
ranges 2007  Treated  Untreated  
Ash % 3.96 3.91 3.81 3.28–4.28 
ADF % 37.3 38.0 36.7 34.3–42.8 
Calcium % 0.19 0.19 0.13 0.08–0.19 
Zinc mg/kg 48.2 47.8 42.9 19.9–57 
Myristic acid % rel. 0.65 0.65 0.76 0.72–1.01 
Palmitic acid % rel. 22.51 22.44 23.10 20.10–24.97 
Palmitoleic acid % rel. 0.45 0.45 0.51 0.50–0.74 
Stearic acid % rel. 2.86 2.87 2.61 2.47–3.28 
Cis-oleic acid % rel. 0.84 0.83 0.90 0.82–1.70 
Oleic acid % rel. 16.94 16.98 16.67 16.96–21.12 
Linoleic acid % rel. 54.12 54.16 53.77 47.26–53.62 
α-Linolenic acid % rel. 0.17 0.17 0.16 0.12–0.17 
Gadoleic acid % rel. NS 0.06 0.06 0.05–0.07 
Lignoceric acid % rel. NS 0.07 0.07 0.04–0.12 
Gossypol free NS 0.55 0.57 0.45–0.83 
Gossypol total NS 1.00 1.01 0.65–1.09 
Phytic acid % 1.36 1.32 1.19 0.72–1.96 
1 Components for which statistically significant differences were identified between T304-40 (treated or untreated) and the 
conventional counterpart are shown. For components where statistically significant treatment  site interactions were seen, 
significance was considered to exist when a majority (> 50 %) of the sites showed a statistically significant difference when 
analysed separately. Fatty acids are in % relative to all fatty acids. NS, not statistically significant. 
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Table 3: Mean values for constituents in seeds of cotton T304-40 and its conventional counterpart 
Coker 315 harvested in the EU in 2008 (T304-40 treated or untreated with glufosinate ammonium) for 
which statistically significant differences were identified by the statistical analysis 
Component
1
 
T304-40 
 
Conventional 
counterpart  
Reference 
ranges 2008  Treated  Untreated  
Fat % 23.6 23.3 22.0 20.8–26.1 
Total carbohydrate % 43.9 43.9 46.0 44.3–51.5 
ADF % 40.6 NS 37.8 36.0–40.4 
Calcium % 0.18 0.17 0.10 0.10–0.19 
Potassium % 1.13 1.10 1.17 1.04–1.21 
Zinc mg/kg 34.0 36.8 45.3 28.5–50.4 
Palmitic acid % rel. 22.50 22.59 22.96 20.35–23.62 
Margaric acid % rel. 0.11 0.11 0.08 0.08–0.11 
Stearic acid % rel. 2.97 3.02 2.62 2.41–3.19 
Oleic acid % rel. 17.43 17.32 16.60 15.83–20.79 
Linoleic acid % rel. 53.89 53.87 54.90 48.63–56.14 
Trans-linoleic acid % rel. 0.05 0.04 0.03 0.02–0.05 
α-Linolenic acid % rel. 0.18 0.16 0.12 0.12–0.17 
Gadoleic acid % rel. 0.05 0.05 0.04 0.04–0.06 
Behenic acid % rel. 0.10 0.08 0.05 0.05–0.10 
Lignoceric acid % rel. 0.07 0.06 0.05 0.04–0.08 
Gossypol free 0.64 0.72 0.56 0.37–1.02 
Gossypol total 0.82 0.89 0.71 0.49–1.30 
Malvalic acid 0.39 0.38 0.31 0.23–0.55 
1 Components for which statistically significant differences were identified between T304-40 (treated or untreated) and the 
conventional counterpart are shown. For components where statistically significant treatment  site interactions were seen, 
significance was considered to exist when a majority (> 50 %) of the sites showed a statistically significant difference when 
analysed separately. Fatty acids are in% relative to all fatty acids. NS, not statistically significant. 
